Interaction of artemisinin protects the activity of antioxidant enzyme catalase: A biophysical study

The major antioxidant enzyme catalase is downregulated and the enzyme activity is compromised in various disease conditions such as malarial and cancer. Hence, the restoration and protection of catalase is a promising therapeutic strategy in disease management. In the present study, for the first time we have demonstrated the protective role of well-known anti-malarial drug Artemisinin (ART) on the time and temperature-induced degradation of bovine liver catalase (BLC) activity. The findings at different time intervals and at higher temperature showed the protective role of ART on BLC activity. Molecular docking studies suggested specific binding of ART on BLC through heme group interface which was further supported by cyclic voltammetry and dynamic light scattering study. The stabilization of BLC in presence of ART was mediated through forming a BLC-ART complex with reduced and shifted electrochemical peak and increased hydrodynamic diameter. ART substantially prevents the temperature-induced reduction in a-helical content with simultaneous increment in other secondary structures like antiparallel, parallel, beta-turn and random coils. Nevertheless, the protective role of ART was accepted from the enhanced thermal stability and increased T-m value of BLC in presence of ART at higher temperatures. Our results uncover the mechanism of interaction between ART with BLC and suggest the protective role of ART towards spatiotemporal alteration of BLC by preventing the structural and molecular change in BLC. Thus, the findings advocate ART as a potential therapeutic drug for diseases associated with reduced catalase activity. (C) 2021 Elsevier B.V. All rights reserved.

Automated summary

The study demonstrates the protective role of the anti-malarial drug Artemisinin (ART) on the activity of catalase enzyme in bovine liver. Molecular docking studies indicate specific binding of ART on the enzyme through the heme group interface. The findings suggest that ART may serve as a potential therapeutic drug for diseases associated with reduced catalase activity.